These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11889306)

  • 1. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus.
    Shaffer CL; Gal P; Ransom JL; Carlos RQ; Smith MS; Davey AM; Dimaguila MA; Brown YL; Schall SA
    Crit Care Med; 2002 Feb; 30(2):343-8. PubMed ID: 11889306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.
    McPherson C; Gal P; Ransom JL; Carlos RQ; Dimaguila MA; Smith M; Davonzo C; Wimmer JE
    Pediatr Cardiol; 2010 May; 31(4):505-10. PubMed ID: 20063159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
    O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
    Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin pharmacokinetics in neonates: the value of volume of distribution as a marker of permanent patent ductus arteriosus closure.
    Gal P; Ransom JL; Weaver RL; Schall S; Wyble LE; Carlos RQ; Brown Y
    Ther Drug Monit; 1991 Jan; 13(1):42-5. PubMed ID: 2057990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous indomethacin infusion may be less effective than bolus infusions for ductal closure in very low birth weight infants.
    de Vries NK; Jagroep FK; Jaarsma AS; Elzenga NJ; Bos AF
    Am J Perinatol; 2005 Feb; 22(2):71-5. PubMed ID: 15731984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two neonatal indomethacin protocols: efficacy and outcome for patent ductus arteriosus closure.
    Rosito G; Sum K; Chorne N
    J Clin Pharm Ther; 2010 Oct; 35(5):589-92. PubMed ID: 20831682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin for patent ductus arteriosus closure. Application of serum concentrations and pharmacodynamics to improve response.
    Gal P; Ransom JL; Schall S; Weaver RL; Bird A; Brown Y
    J Perinatol; 1990 Mar; 10(1):20-6. PubMed ID: 2313390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin dosing strategy and neonatal patent ductus arteriosus closure.
    Rathi P; Messina C; Mintzer JP
    J Neonatal Perinatal Med; 2019; 12(4):411-417. PubMed ID: 31561393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
    Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
    Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.
    Grosfeld JL; Chaet M; Molinari F; Engle W; Engum SA; West KW; Rescorla FJ; Scherer LR
    Ann Surg; 1996 Sep; 224(3):350-5; discussion 355-7. PubMed ID: 8813263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.
    Smyth JM; Collier PS; Darwish M; Millership JS; Halliday HL; Petersen S; McElnay JC
    Br J Clin Pharmacol; 2004 Sep; 58(3):249-58. PubMed ID: 15327584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?
    Kaempf JW; Wu YX; Kaempf AJ; Kaempf AM; Wang L; Grunkemeier G
    J Perinatol; 2012 May; 32(5):344-8. PubMed ID: 21818064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile and management of PDA in neonates.
    Shanthala CC; Maiya PP; Vishwanath D; Banakappa N; Swamy PM; Desai N; Ravikishore ; Srinivas KH
    Indian J Pediatr; 1997; 64(5):667-70. PubMed ID: 10771900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteral paracetamol or Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Preterm Neonates: A Randomized Controlled Trial.
    Dash SK; Kabra NS; Avasthi BS; Sharma SR; Padhi P; Ahmed J
    Indian Pediatr; 2015 Jul; 52(7):573-8. PubMed ID: 26244949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
    Srinivasjois RM; Nathan EA; Doherty DA; Patole SK
    J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus.
    Wiest DB; Pinson JB; Gal PS; Brundage RC; Schall S; Ransom JL; Weaver RL; Purohit D; Brown Y
    Clin Pharmacol Ther; 1991 May; 49(5):550-7. PubMed ID: 2029829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.